Mature B-Cell Non-Hodgkin Lymphoma — Trials

Mature B-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

2,506 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 792
Recruiting: 401
Ph III recruiting: 40
Growth YoY: +8%
Industry share: 24%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (393)

clinicaltrialsPublishedShowing 651–700 of 2,506 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07443514	Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma	recruiting	N/A	3	Institute of Oncology LjubljanaOTHER	1	Mar 2, 2026	clinicaltrials
NCT03919175	Umbralisib and Rituximab as Initial Therapy for Patients With Follicular Lymphoma and Marginal Zone Lymphoma	terminated	Phase 2	18	Massachusetts General HospitalOTHER	1	Feb 27, 2026	clinicaltrials